2m 2m 2m 2m 2m 2m 2m
XERIS BIPH HLDG (XERS)
NASDAQ
$10.86+$0.07 (+0.65%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.0BMarket Cap
- 18.91%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
XERIS BIPH HLDG (XERS)
$10.86+$0.07 (+0.65%)
XERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.79 | ||
Change | -$0.35 (-3.10%) | ||
Open | $11.14 | ||
High | $11.28 | ||
Low | $10.77 | ||
Previous Close | $11.13 | ||
Volume | 1,681,557 | ||
30-Day Average Volume | 3,328,773 | ||
1-Week Change | 10.39% | ||
1-Month Change | 22.56% | ||
1-Year Change | 18.91% | ||
3-Year Change | 519.83% | ||
5-Year Change | 447.46% | ||
Fundamentals | |||
Shares Outstanding | 182.3M | ||
Total Assets | $411.9M | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $91.0M | ||
Net Income | -$31.1M | ||
Free Cash Flow | $8.5M | ||
EBIT | -$31.1M | ||
EBITDA | -$28.4M | ||
Net Working Capital | $85.2M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -74 | ||
Enterprise Value/Revenue | 23 | ||
P/B | -202 | ||
P/E | -60 | ||
PEG | 0 | ||
Price/Free Cash Flow | 232 | ||
Price/Operating Cash Flow | 238 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue